Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $169.58 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $169.58 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $169.58 | 10 | GlaxoSmithKline, LLC. ($169.58) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RESPIRATORY | ||||||
About Dr. John Custis, MD
Dr. John Custis, MD is a Internal Medicine healthcare provider based in Gresham, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770561813.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Custis, MD has received a total of $169.58 in payments from pharmaceutical and medical device companies, with $169.58 received in 2024. These payments were reported across 10 transactions from 1 company. The most common payment nature is "Food and Beverage" ($169.58).
Practice Information
- Specialty Internal Medicine
- Location Gresham, OR
- Active Since 01/09/2006
- Last Updated 12/21/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770561813
Products in Payments
- TRELEGY ELLIPTA (Drug) $114.72
- NUCALA (Biological) $54.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gresham
Edward Cheng, M.d,, M.D,
Internal Medicine — Payments: $39,176
Dr. Avnish Tripathi, M.d., Ph.d., M.p.h, M.D., PH.D., M.P.H
Internal Medicine — Payments: $12,554
Jennifer Rodriguez, M.d, M.D
Internal Medicine — Payments: $10,858
Steven Maness, M.d, M.D
Internal Medicine — Payments: $6,102
Angela Gibbs, Md, MD
Internal Medicine — Payments: $1,551
Craig Davis, Md, MD
Internal Medicine — Payments: $804.46